Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,854
datasets available to search
ShareScore release 0.9.0
Dataset results
2,854 results for “hepatocellular carcinoma”
The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial
ClinicalTrials.gov study NCT04562428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00415155. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Targeted Navigation in Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT06260943. IPD Sharing: NO. Countries: 1. Publications: 0.
Meclizine for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03253289. IPD Sharing: NO. Countries: 1. Publications: 0.
STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06880523. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05981066. IPD Sharing: NO. Countries: 1. Publications: 0.
Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00820157. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HAI or IV of Adebrelimab, Combined with Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06737913. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06527495. IPD Sharing: NO. Countries: 1. Publications: 0.
Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07081633. IPD Sharing: YES. Countries: 2. Publications: 0.
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
ClinicalTrials.gov study NCT06265350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)
ClinicalTrials.gov study NCT01837381. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
ClinicalTrials.gov study NCT05352204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological
ClinicalTrials.gov study NCT06325826. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT
ClinicalTrials.gov study NCT04709380. IPD Sharing: NO. Countries: 1. Publications: 0.
Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.
ClinicalTrials.gov study NCT03448757. IPD Sharing: NO. Countries: 1. Publications: 0.
The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)
ClinicalTrials.gov study NCT07064681. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells
ClinicalTrials.gov study NCT00562666. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06215651. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05003700. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.